Abstract:Genus Rubia fell into about 70 species distributed widely around the world, a total of 36 species and 2 varieties were reported from China. The extracts and phytochemicals of Rubia plants had drawn considerable attention due to their potent bioactivities. As the two major ingredients from these plants, pentacyclic triterpenes and cyclopeptides were becoming a hot topic over the past twenty years for their remarkable anticancer, antioxidant and other effects. This paper compiled all 65 terpenes and 44 cyclopept… Show more
“…The roots and rhizomes of the Rubia plants, including Rubia cordifolia , were recorded as a traditional Chinese medicine in Chinese Pharmacopeia and have been widely used for the treatment of menoxenia, rheumatism, contusions, and tuberculosis. Rubiaceae-type cyclopeptides (RAs), quinones, and triterpenes have been isolated from the Rubia plants 3 – 6 . Among them, RA-VII, a Rubiaceae-type cyclopeptide, was reported to have undergone phase I clinical trials at the NCI as an anticancer drug in Japan in 1990s 3 .…”
Section: Introductionmentioning
confidence: 99%
“…Among them, RA-VII, a Rubiaceae-type cyclopeptide, was reported to have undergone phase I clinical trials at the NCI as an anticancer drug in Japan in 1990s 3 . To date, 56 RAs have been isolated from higher plants 6 – 10 , and these compounds have attracted considerable attention over the past three decades because of their unique bicyclic structures and amazing antitumour activities in vitro and in vivo, particularly RA-VII and RA-V (Fig. 1a ).…”
Rubiaceae-type cyclopeptides (RAs) are a type of plant cyclopeptides from the Rubia that have garnered significant attention owing to their unique bicyclic structures and amazing antitumour activities. Our recent work has shown that RAs suppress inflammation and angiogenesis and induce apoptosis. However, the underlying mechanism and targets remained unknown. Nuclear factor κB (NF-κB) signaling pathway plays a critical role in these biological processes, prompting us to investigate whether and how RAs affect this pathway. By screening compound libraries using NF-κB-dependent luciferase reporter, we observed that RA-V is the best NF-κB inhibitor. Further experiments demonstrated that RA-V interrupted the TAK1–TAB2 interaction and targeted TAK1 in this pathway. Moreover, RA-V prevented endotoxin shock and inhibited NF-κB activation and tumor growth in vivo. These findings clarify the mechanism of RA-V on NF-κB pathway and might account for the majority of known bioactivities of RA-V, which will help RA-V develop as new antiinflammatory and antitumour therapies.
“…The roots and rhizomes of the Rubia plants, including Rubia cordifolia , were recorded as a traditional Chinese medicine in Chinese Pharmacopeia and have been widely used for the treatment of menoxenia, rheumatism, contusions, and tuberculosis. Rubiaceae-type cyclopeptides (RAs), quinones, and triterpenes have been isolated from the Rubia plants 3 – 6 . Among them, RA-VII, a Rubiaceae-type cyclopeptide, was reported to have undergone phase I clinical trials at the NCI as an anticancer drug in Japan in 1990s 3 .…”
Section: Introductionmentioning
confidence: 99%
“…Among them, RA-VII, a Rubiaceae-type cyclopeptide, was reported to have undergone phase I clinical trials at the NCI as an anticancer drug in Japan in 1990s 3 . To date, 56 RAs have been isolated from higher plants 6 – 10 , and these compounds have attracted considerable attention over the past three decades because of their unique bicyclic structures and amazing antitumour activities in vitro and in vivo, particularly RA-VII and RA-V (Fig. 1a ).…”
Rubiaceae-type cyclopeptides (RAs) are a type of plant cyclopeptides from the Rubia that have garnered significant attention owing to their unique bicyclic structures and amazing antitumour activities. Our recent work has shown that RAs suppress inflammation and angiogenesis and induce apoptosis. However, the underlying mechanism and targets remained unknown. Nuclear factor κB (NF-κB) signaling pathway plays a critical role in these biological processes, prompting us to investigate whether and how RAs affect this pathway. By screening compound libraries using NF-κB-dependent luciferase reporter, we observed that RA-V is the best NF-κB inhibitor. Further experiments demonstrated that RA-V interrupted the TAK1–TAB2 interaction and targeted TAK1 in this pathway. Moreover, RA-V prevented endotoxin shock and inhibited NF-κB activation and tumor growth in vivo. These findings clarify the mechanism of RA-V on NF-κB pathway and might account for the majority of known bioactivities of RA-V, which will help RA-V develop as new antiinflammatory and antitumour therapies.
“…In the present study, a series of novel T-OA analogues were designed and synthesized via amino condensation reaction, inspired by the potent bioactivities of ligustrazine amide derivatives and potent advantages of pentacyclic triterpenes on antitumor effects [6][7][8][9]; refer to the structural features of T-OA, OA, glycyrrhetinic acid (GA), ursolic acid (UA), betulinic acid (BA), and TMP served as starting materials. Firstly, pentacyclic triterpenes evolved into 3-keto or/and 3-acetyl derivatives; then, a mixture of these derivatives and TMP-NH 2 (3, 5, 6-trimethylpyrazine-2-methanamine) could provide a series of novel T-OA analogues under special conditions.…”
The lead compound T-OA, 3b-hydroxyolean-12-en-28-oic acid-(3,5,6-trimethylpyrazine-2-yl) methyl ester, which exhibited promising anticancer effects in vitro and in vivo, has previously been reported. According to the structural features, a series of novel T-OA analogues were synthesized via amino condensation reaction. These analogues' cytotoxic activities were evaluated on five cancer cell lines (Bel-7402, HepG-2, HT-29, Hela, BGC-823) and hepatic stellate cell line (HSC-6). Among the candidates, compounds 8 and 16 showed promising effects; 3b-hydroxy-lup-20(29)-ene-28-oic acid-(3,5,6-trimethylpyrazin-2-yl) methyl amine (16) even possessed superior bioactivities to positive drugs (cisplatin and ursolic acid), which was worthy of further study. In addition, structure-activity relationships and Clog P values of T-OA analogues were briefly discussed.
“…The anthraquinones of Rubiaceae have biological activities such as antimicrobial, hypotensive, analgesic, antimalarial, antioxidant, antileukemic, and mutagenic effects (2). Studies in Rubia plants have led to the separation of biological components, including 148 anthraquinones and naphthoquinones, 65 terpenes, and 44 cyclopeptides, some of them have strong anticancer and antioxidant activities (3). On the other hand, some compounds of madder such as lucidin have shown mutagenic effects in bacterial and mammalian systems (5).…”
Background: Few past studies have indicated antispasmodic and anti-oxidative effects of some species of Rubiaceae. Objectives: This study aimed to investigate the effect of hydroalcoholic extract of Rubia tinctorum L. (madder) root on the rat-isolated aorta and possible protective effects against the damage caused by hyperglycemic environment. Methods: The isolated thoracic aorta ring (with or without endothelium) was treated with phenylephrine (10 -6 M) or KCl (80 mM)
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.